The use of adalimumab to overcome delayed wound healing after wide excision for hidradenitis suppurativa

Eur J Dermatol. 2024 Apr 1;34(2):200-201. doi: 10.1684/ejd.2024.4650.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab* / therapeutic use
  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Female
  • Hidradenitis Suppurativa* / drug therapy
  • Hidradenitis Suppurativa* / surgery
  • Humans
  • Male
  • Wound Healing* / drug effects

Substances

  • Adalimumab
  • Anti-Inflammatory Agents